Buyback Insider Conviction: 8-K Repurchase Plus Insider Buys

For each ticker, correlates a material 8-K event with insider open-market buying in the days around it, scores conviction 0 to 100, and tiers events high_conviction, elevated, or watch. Insiders buying right as a material event files is the signal. Pure EDGAR data, no API keys.

For each ticker, finds recent Schedule 13D and 13G filings on EDGAR and correlates them with insider open-market buying around the filing, scores conviction 0 to 100, and tiers each as activist_confirmed, accumulation, or watch. An activist filing while insiders buy is the signal.

For each ticker, correlates recent FDA wins on openFDA (drug approvals, device PMA, 510(k) clearances) with insider open-market buying around the decision date, scores conviction 0 to 100, and tiers each as approval_confirmed, accumulation, or watch.

Find companies where insiders are buying on the open market AND filing material 8-K catalysts. Chains SEC Form 4 with 8-K events, joins on issuer CIK, and scores each company 0-100 by conviction tier. Core tier is 100% SEC EDGAR, no antibot risk. Pay per scored company.

For each ticker, joins insider open-market buying (SEC Form 4) with social chatter on Reddit and Hacker News, scores 0 to 100, and tiers tickers converging, insider_only, buzz_only, or watch. Insiders buying while the crowd starts talking is the signal. Pure public data, no API keys.

Insider Buying Signal Scraper

glowing_glove/insider-buying-signal-scraper

Collect public insider and holder-change filing signals and return compact market intelligence rows for stock research.

Scores US insider trades on conviction. Separates genuine open-market buys from option exercises and 10b5-1 planned sales, weights by officer seniority and stake change, and flags multi-insider buy clusters.

Joins accelerating federal contract awards (USAspending) with insider open-market buying (SEC Form 4), scores 0 to 100, and tiers companies converging, contract_only, insider_only, or watch. A contractor winning surging government dollars while insiders buy is the signal. Public data, no API keys.

For each biotech company, correlates clinical pipeline progress (ClinicalTrials.gov) and research momentum (PubMed) with open-market insider buying (SEC Form 4), scores convergence 0 to 100, and tiers companies catalyst, clinical lead, insider lead, or watch. An advancing asset plus insiders buying.

Insider Buying Signal Monitor

glowing_glove/insider-buying-signal-monitor

Collect public insider and holder-change filing signals and return compact market intelligence rows for stock watchlists.